If your institution subscribes to this resource, and you don't have a MyAccess Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Antineoplastic, poly ADP-ribose polymerase inhibitor
Breast cancer with a germline BRCA mutation
Niraparib, olaparib, rucaparib
Chapter 67. Pathway-Targeted Therapies: Monoclonal Antibodies, Protein Kinase Inhibitors, and Various Small Molecules > Inhibitors of Poly (ADP-Ribose) Polymerase
eChapter 2018: The Goodman & Gilman Year in Review New and Noteworthy FDA Approvals